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This Month in the Journal
Repair of DNA damage occurs via several pathways that
have been conserved, in their basic form, in all eukar-
yotes. Leadon (p. 1259) begins this month’s series on
the genetics of human DNA repair with a discussion of
transcription-coupled repair. Both nucleotide-excision
repair and mismatch repair occur preferentially in tran-
scribed genes—and on the transcribed strand of those
genes—and Leadon argues that genes underlying Cock-
ayne syndrome and one form of xeroderma pigmento-
sum, as well as the breast cancer gene BRCA1, help to
couple transcription to repair. Petrini (p. 1264) shows
that Nijmegen breakage syndrome is a disorder of the
double-strand break–repair system, and he compares the
function of the human NBS1 protein complex to that of
a DNA-repair complex that induces cell-cycle arrest in
yeast. Maizels (p. 1270) discusses the need for double
strand–break repair and mismatch repair at several steps
in the maturation of immune cells. She focuses, in par-
ticular, on the recombination events required for im-
munoglobulin-class switching, for which the Bloom syn-
drome DNA helicase seems to be required. Bogenhagen
(p. 1276) shows that DNA repair of several classes oc-
curs in mammalian mitochondria, despite some pre-
mature claims to the contrary. Some nuclear
DNA–repair factors are alternatively processed and ex-
pressed in the mitochondrion, so defects in the corre-
sponding genes may affect the stability of both the nu-
clear and the mitochondrial genomes. Finally, Oliver et
al. (p. 1282) discuss an unusual intranuclear protein
modification, the addition of polymers of ADP-ribose,
to chromatin proteins, DNA-repair molecules, and reg-
ulators of the cell cycle. This modification, carried out
by the protein PARP, is required for base-excision repair.
Efficient apoptosis, a physiologically benign form of cell
death, requires that PARP be proteolytically inactivated.
Comprehensive Analysis of TSC1 and TSC2, by Jones
et al. (p. 1305)
TSC1 and TSC2 encode hamartin and tuberin, tumor-
suppressor proteins that collaborate to repress the
growth of hamartomas in the brain and many other
tissues. Defects in either of these genes cause tuberous
sclerosis (TSC), a clinically variable tumor disorder.
Jones and colleagues have performed the largest survey,
to date, of familial and sporadic cases of strictly defined
TSC, and they now report on the range of mutations in
both genes among 120 unrelated people. Among pro-
bands in this group who had no family history of TSC,
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a considerable majority carried mutations in TSC2, but
defects in TSC1 and TSC2 are evenly distributed among
familial cases. Jones et al. suggest that TSC2 defects may
lead to more-severe disease and, hence, to a lower prob-
ability of the affected person reproducing. The authors
describe 42 novel and 38 previously reported lesions in
TSC2 in their group. The 19 known missense mutations
and short in-frame deletions, which may be informative
in structure/function studies, appear to cluster in several
locations within the protein.
COX II Mutation, by Clark et al. (p. 1330)
Cytochrome c oxidase, also known as “complex IV” of
the mitochondrial electron-transport chain, consists of
13 subunits, 3 of which are encoded by the mitochon-
drial genome. Clark et al. have identified, in a mother
and son with progressive ataxia and muscle wasting, a
heteroplasmic point mutation in the mitochodrially en-
coded gene for the subunit II of this complex. Muscle
biopsies and PCR analysis of individual muscle fibers
show that, in fibers that lack cytochrome c oxidase ac-
tivity, mtDNA with the point mutation predominates
over wild-type mtDNA. This mutation destroys the in-
itiator methionine codon in this gene and appears to
block all synthesis of subunit II, although other mito-
chondrially expressed proteins accumulate at normal
levels. Surprisingly, expression of the subunit II mRNA
is also specifically reduced in cells carrying a substantial
proportion of the mutant mtDNA. Clark and colleagues
speculate that the stability of mitochondrial mRNA may
be diminished in the absence of translation.
Subtle SMN1 Mutations in SMA Patients, by Wirth et
al. (p. 1340); and Promoters of SMN and SMNc, by
Echaniz-Laguna et al. (p. 1365)
Spinal muscle atrophy (SMA) results from lesions in a
5q13 duplicated region that contains two nearly iden-
tical copies of at least four genes. Despite this complex
structure, it now appears that the critical sequence un-
derlying SMA is the telomeric copy of the SMN gene
(described as “SMN1” by Wirth et al. and as “SMN”
by Echaniz-Laguna et al.; standard nomenclature in this
field would certainly be welcome). Other linked genes,
such as the neuronal apoptosis-inhibitory protein
(NAIP) gene and the centromeric copy of SMN, termed
“SMN2” or “SMNc,” have also been suggested to con-
tribute to the condition. The most common cause of
SMA is the homozygous deletion of all or part of the
telomeric SMN1 gene, but point mutations in this gene
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are also observed. Wirth and co-workers have refined a
quantitative PCR-based assay to determine the number
of copies of SMN1 or SMN2 per genome. They observe
single-copy deletions of SMN1 in obligate carriers and
in compound heterozygotes who bear novel point mu-
tations in their remaining copy of SMN1. In one case,
Wirth et al. show that a gene conversion has replaced
one copy of SMN1 with SMN2, a change that is asso-
ciated with SMA. All of these results appear to indicate
that SMN2 cannot substitute for SMN1, although dif-
ferences in SMN2 copy number seem to account for
some of the clinical variability among patients with iden-
tical SMN1 genotypes. The nonequivalence of these two
nearly identical genes is especially surprising in light of
results from Echaniz-Laguna et al., who show here that
the promoters of these genes are also quite similar. Se-
quences derived from upstream regions of SMN1 and
SMN2 drive expression of a reporter gene equally effi-
cient in cultured cells. The authors suggest that differ-
ences in expression level between these genes occur at
the posttranscriptional level, perhaps by affecting
mRNA stability.
Androgen Receptor in BRCA1 Breast Cancer, by
Rebbeck et al. (p. 1371)
The risk of breast cancer due to mutations in BRCA1
is difficult to predict for an individual woman. Here,
Rebbeck et al. consider one potential interacting gene,
the X-linked androgen receptor (AR) gene, which carries
a CAG repeat whose length is inversely correlated with
AR-expression level. Because AR function alters breast
cancer–cell development in culture, Rebbeck et al. ex-
amine the variation of trinucleotide-repeat length in this
gene in 304 women with inherited BRCA1 mutations,
half of whom had been diagnosed with breast cancer.
Of the several possible correlations that the authors ex-
amine, one emerges as statistically significant: As the
length of the longer CAG repeat increases (and, presum-
ably, as the expression of the weaker AR allele drops),
women are at greater risk of early-onset disease. Reb-
beck et al. suggest that random X inactivation renders
BRCA1 heterozygotes who carry one weakly expressed
AR allele especially susceptible to tumor development.
This model predicts that tumors in these women should
derive preferentially from clones of cells in which the
longer AR allele occurs on the active X chromosome.
Recombination Suppression at RNU2-BRCA1, by Liu
and Barker (p. 1427)
“Hot” and “cold” spots for meiotic recombination oc-
cur on all chromosomes and account for the differences
between physical distances and recombination distances
between markers. Here, Liu and Barker define the limits
of one of the most extended cold spots, a region of 1250
kb surrounding BRCA1. Using polymorphisms that
cover nearly 2 Mb in this region of 17q, Liu and Barker
infer haplotypes for 275 randomly ascertained Cauca-
sians and 34 Asian Americans. For the 250-kb core re-
gion, these haplotypes fall into three major groups, and
the authors reconstruct a possible evolutionary relation-
ship among the major groups and subgroups. All steps
in this pathway result from the accumulation of muta-
tions, and there is no evidence that recombination has
occurred across this region during the estimated 4,000
generations that separate Asians from Europeans. Hap-
lotypes over autosomal recombination cold spots might
be used much like mitochondrial or Y-chromosome
markers, to help deduce historical relations among
peoples.
Meiotic Transmission of a Neocentromere, by Tyler-
Smith et al. (p. 1440)
Normal centromeres consist of hundreds to thousands
of kilobases of simple repetitive “alphoid” DNA to
which at least six specific chromatin proteins, the
CENP’s, bind during mitosis. However, cell-culture stud-
ies show that alphoid sequence is not essential for cen-
tromere function and that CENP-A, -C, and -E can bind
to any of a large number of chromosomal loci when
“latent neocentromeres” at such loci become activated.
Because both acentric and dicentric chromosomes are
lost from a population of dividing cells, stable trans-
mission requires that exactly one centromere or neocen-
tromere on a chromosome be active at any time. Tyler-
Smith and colleagues observed during routine karyotyp-
ing that the Y chromosome of a male fetus lacked a
constriction at the usual location but contained a con-
striction at Yq12. Because this karyotypic feature was
also seen in the father and a paternal uncle, Tyler-Smith
et al. conclude that the Yq12 neocentromere has been
active—and that the normal Y centromere has been in-
active—for at least three generations in this family. In
cells from this family, the Y-chromosomal alphoid array
at the inactivated centromere is unusually short, and
CENP-B staining is seen only at the neocentromere. Al-
though the neocentromere appears to function ade-
quately in meiotic chromosome segregation, the presence
of 45,X cells among the lymphocytes from the father
and uncle indicates that it is not entirely equivalent to
the centromere in a normal Y chromosome.
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